Peter Mouritzen's Biography

Home
|
Agenda
- Agenda Day 1
- Agenda Day 2
|
Exhibition
|

Peter Mouritzen, Vice President, Exiqon A/S

Peter Mouritzen, MSc, PhD, is Director of Product development at Exiqon Life Sciences. Exiqon Life Sciences develop molecular biology tools for LNA™ based detection of nucleic acids and functional analysis. In particular the miRCURY brand is a set of tools that support the entire workflow in miRNA research from sample preparation, over miRNA profiling with arrays and qPCR, including validation by qPCR and in situ hybridization, to functional analysis with LNA™ miRNA inhibitors.

Early Detection of Colorectal Cancer from Patient Blood Plasma using microRNA-Based RT-qPCR

Thursday, 8 September 2011 at 11:45

Add to Calendar ▼2011-09-08 11:45:002011-09-08 12:45:00Europe/LondonEarly Detection of Colorectal Cancer from Patient Blood Plasma using microRNA-Based RT-qPCRRNAi and miRNA Europe in MunichMunichSELECTBIOenquiries@selectbiosciences.com

The miRCURY LNA™ Universal RT miRNA PCR platform allows miRNome profiling from just 35µL of plasma. This high sensitivity has enabled DX programs at Exiqon where blood plasma samples from cancer patients are screened for miRNA with aberrant expression profiles. The objective of this work is to develop minimally invasive methods for early diagnosis of cancer. The characteristics and performance of the LNA™ based miRNA PCR platform will be discussed.

Add to Calendar ▼2011-09-08 00:00:002011-09-09 00:00:00Europe/LondonRNAi and miRNA EuropeRNAi and miRNA Europe in MunichMunichSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors